BioSpace News Archive

New member brings 25 years of experience in health care delivery and management, public policy, and public health

Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today announced the initiation and design of its pivotal global Phase 3 trial (ATTRibute-CM) of AG10 in patients with transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM).

Opsens Inc. is pleased to announce that it has entered into an $8 M credit agreement with CIBC Innovation Banking.

MYOS RENS Technology Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced that it has signed an agreement with Kansas State University College of Veterinary Medicine

FirstLight Home Care, an award-winning provider of non-medical home care, announced today it will open a new location in the Atlanta area in Decatur, Georgia, in 2019.

FirstLight Home Care, a leading national provider of non-medical home care, has been ranked No. 18 on Franchise Gator’s Top 100 Franchises of 2019 and No. 30 on the Fastest Growing Franchise list.

PolarityTE, Inc. (NASDAQ: PTE) announced today that its platform technology will be featured at the 2019 Pacific Operational Science and Technology (POST) Conference, co-sponsored by the United States Indo-Pacific Command and TechConnect, held March 4-8, 2019.

Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Company”), an emerging Orthopaedic and Sports Medicine Technology company, today announced that following a formal meeting with the FDA, its development program to date has exceeded expectations.

Medicine-On-Time, a CSS Health Company, has just launched a new system that improves speed, accuracy and service when building blister packs for customized medication regimens

TARGET PharmaSolutions, Inc., a real-world clinical data solutions company, is pleased to announce that Novartis Pharma AG is the first industry partner to provide multi-year support to TARGET-DERM registry.